Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

NYSE:XPOF - New York Stock Exchange, Inc. - US98422X1019 - Common Stock - Currency: USD

17.43  +0.41 (+2.41%)

After market: 17.43 0 (0%)

Fundamental Rating

4

Overall XPOF gets a fundamental rating of 4 out of 10. We evaluated XPOF against 134 industry peers in the Hotels, Restaurants & Leisure industry. While XPOF is still in line with the averages on profitability rating, there are concerns on its financial health. XPOF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year XPOF was profitable.
In the past year XPOF had a positive cash flow from operations.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

XPOF's Return On Assets of -5.23% is on the low side compared to the rest of the industry. XPOF is outperformed by 79.39% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.83%, XPOF belongs to the top of the industry, outperforming 83.21% of the companies in the same industry.
Industry RankSector Rank
ROA -5.23%
ROE N/A
ROIC 13.83%
ROA(3y)-4.27%
ROA(5y)-5.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

The Operating Margin of XPOF (18.76%) is better than 76.34% of its industry peers.
The Gross Margin of XPOF (75.01%) is better than 91.60% of its industry peers.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 18.76%
PM (TTM) N/A
GM 75.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.14%
GM growth 5Y6.53%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so XPOF is still creating some value.
Compared to 1 year ago, XPOF has less shares outstanding
The debt/assets ratio for XPOF is higher compared to a year ago.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.17, we must say that XPOF is in the distress zone and has some risk of bankruptcy.
XPOF has a worse Altman-Z score (0.17) than 81.68% of its industry peers.
The Debt to FCF ratio of XPOF is 278.36, which is on the high side as it means it would take XPOF, 278.36 years of fcf income to pay off all of its debts.
XPOF has a Debt to FCF ratio of 278.36. This is in the lower half of the industry: XPOF underperforms 65.65% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 278.36
Altman-Z 0.17
ROIC/WACC1.37
WACC10.07%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

A Current Ratio of 1.02 indicates that XPOF should not have too much problems paying its short term obligations.
XPOF has a Current ratio (1.02) which is comparable to the rest of the industry.
A Quick Ratio of 0.90 indicates that XPOF may have some problems paying its short term obligations.
XPOF has a Quick ratio (0.90) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.9
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 117.53% over the past year.
Looking at the last year, XPOF shows a quite strong growth in Revenue. The Revenue has grown by 9.00% in the last year.
Measured over the past years, XPOF shows a very strong growth in Revenue. The Revenue has been growing by 39.98% on average per year.
EPS 1Y (TTM)117.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.36%
Revenue 1Y (TTM)9%
Revenue growth 3Y44.05%
Revenue growth 5Y39.98%
Sales Q2Q%0.07%

3.2 Future

XPOF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 95.47% yearly.
XPOF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.75% yearly.
EPS Next Y140.12%
EPS Next 2Y154.48%
EPS Next 3Y120.86%
EPS Next 5Y95.47%
Revenue Next Year2.51%
Revenue Next 2Y4.99%
Revenue Next 3Y6.61%
Revenue Next 5Y7.75%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

XPOF is valuated quite expensively with a Price/Earnings ratio of 102.53.
Based on the Price/Earnings ratio, XPOF is valued a bit more expensive than the industry average as 63.36% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of XPOF to the average of the S&P500 Index (28.47), we can say XPOF is valued expensively.
XPOF is valuated reasonably with a Price/Forward Earnings ratio of 11.21.
XPOF's Price/Forward Earnings ratio is rather cheap when compared to the industry. XPOF is cheaper than 93.13% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 92.74. XPOF is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 102.53
Fwd PE 11.21
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as XPOF.
Based on the Price/Free Cash Flow ratio, XPOF is valued a bit more expensive than 64.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 668.15
EV/EBITDA 14.85
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 120.86% in the coming years.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y154.48%
EPS Next 3Y120.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPONENTIAL FITNESS INC-A

NYSE:XPOF (2/4/2025, 8:17:14 PM)

After market: 17.43 0 (0%)

17.43

+0.41 (+2.41%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners77.34%
Inst Owner Change-0.11%
Ins Owners4.06%
Ins Owner Change-1.67%
Market Cap841.87M
Analysts82.67
Price Target19.74 (13.25%)
Short Float %12.2%
Short Ratio6.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP-20.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-113.82%
Min EPS beat(2)-114.66%
Max EPS beat(2)-112.98%
EPS beat(4)0
Avg EPS beat(4)-75.83%
Min EPS beat(4)-114.66%
Max EPS beat(4)-27.04%
EPS beat(8)0
Avg EPS beat(8)-207.46%
EPS beat(12)0
Avg EPS beat(12)-176.47%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.54%
Min Revenue beat(2)-10.3%
Max Revenue beat(2)3.21%
Revenue beat(4)2
Avg Revenue beat(4)-0.04%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)7.98%
Revenue beat(8)6
Avg Revenue beat(8)2.69%
Revenue beat(12)10
Avg Revenue beat(12)6.29%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.25%
PT rev (3m)-3.25%
EPS NQ rev (1m)-1.89%
EPS NQ rev (3m)13.92%
EPS NY rev (1m)-0.88%
EPS NY rev (3m)-28.48%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-15.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 102.53
Fwd PE 11.21
P/S 2.58
P/FCF 668.15
P/OCF 103.33
P/B N/A
P/tB N/A
EV/EBITDA 14.85
EPS(TTM)0.17
EY0.98%
EPS(NY)1.55
Fwd EY8.92%
FCF(TTM)0.03
FCFY0.15%
OCF(TTM)0.17
OCFY0.97%
SpS6.76
BVpS-0.81
TBVpS-6.62
PEG (NY)0.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.23%
ROE N/A
ROCE 16.21%
ROIC 13.83%
ROICexc 14.8%
ROICexgc 72.15%
OM 18.76%
PM (TTM) N/A
GM 75.01%
FCFM 0.39%
ROA(3y)-4.27%
ROA(5y)-5.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.14%
GM growth 5Y6.53%
F-Score3
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 278.36
Debt/EBITDA 4.35
Cap/Depr 39.67%
Cap/Sales 2.11%
Interest Coverage 1.49
Cash Conversion 10.36%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.9
Altman-Z 0.17
F-Score3
WACC10.07%
ROIC/WACC1.37
Cap/Depr(3y)71.01%
Cap/Depr(5y)78.33%
Cap/Sales(3y)4.32%
Cap/Sales(5y)4.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.36%
EPS Next Y140.12%
EPS Next 2Y154.48%
EPS Next 3Y120.86%
EPS Next 5Y95.47%
Revenue 1Y (TTM)9%
Revenue growth 3Y44.05%
Revenue growth 5Y39.98%
Sales Q2Q%0.07%
Revenue Next Year2.51%
Revenue Next 2Y4.99%
Revenue Next 3Y6.61%
Revenue Next 5Y7.75%
EBIT growth 1Y42.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.04%
EBIT Next 3Y41.35%
EBIT Next 5Y34.38%
FCF growth 1Y-96.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.02%
OCF growth 3YN/A
OCF growth 5Y111.35%